Eiger BioPharmaceuticals (EIGR) Reports Q2 Loss of $1.87/Share

Eiger BioPharmaceuticals (NASDAQ: EIGR) reported Q2 EPS of ($1.87), versus ($13.34) reported last year.

For earnings history and earnings-related data on Eiger BioPharmaceuticals (EIGR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• SanDisk upgraded at JPMorgan after investor day; shares climb